The  ||| S:0 E:4 ||| DT
first  ||| S:4 E:10 ||| JJ
crystal  ||| S:10 E:18 ||| NN
structures  ||| S:18 E:29 ||| NNS
of  ||| S:29 E:32 ||| IN
RNA-PNA  ||| S:32 E:40 ||| JJ
duplexes  ||| S:40 E:49 ||| NN
and  ||| S:49 E:53 ||| CC
a  ||| S:53 E:55 ||| DT
PNA-PNA  ||| S:55 E:63 ||| JJ
duplex  ||| S:63 E:70 ||| NN
containing  ||| S:70 E:81 ||| VBG
mismatches-toward  ||| S:81 E:99 ||| JJ
anti-sense  ||| S:99 E:110 ||| JJ
therapy  ||| S:110 E:118 ||| NN
against  ||| S:118 E:126 ||| IN
TREDs  ||| S:126 E:132 ||| NNP
PNA  ||| S:132 E:136 ||| NNP
is  ||| S:136 E:139 ||| VBZ
a  ||| S:139 E:141 ||| DT
promising  ||| S:141 E:151 ||| JJ
molecule  ||| S:151 E:160 ||| NN
for  ||| S:160 E:164 ||| IN
antisense  ||| S:164 E:174 ||| JJ
therapy  ||| S:174 E:182 ||| NN
of  ||| S:182 E:185 ||| IN
trinucleotide  ||| S:185 E:199 ||| JJ
repeat  ||| S:199 E:206 ||| NN
disorders ||| S:206 E:215 ||| NNS
.  ||| S:215 E:217 ||| .
We  ||| S:217 E:220 ||| PRP
present  ||| S:220 E:228 ||| VBP
the  ||| S:228 E:232 ||| DT
first  ||| S:232 E:238 ||| JJ
crystal  ||| S:238 E:246 ||| NN
structures  ||| S:246 E:257 ||| NNS
of  ||| S:257 E:260 ||| IN
RNA-PNA  ||| S:260 E:268 ||| JJ
duplexes ||| S:268 E:276 ||| NN
.  ||| S:276 E:278 ||| .
They  ||| S:278 E:283 ||| PRP
contain  ||| S:283 E:291 ||| VBP
CUG  ||| S:291 E:295 ||| JJ
repeats ||| S:295 E:302 ||| NNS
,  ||| S:302 E:304 ||| ,
relevant  ||| S:304 E:313 ||| JJ
to  ||| S:313 E:316 ||| TO
myotonic  ||| S:316 E:325 ||| VB
dystrophy  ||| S:325 E:335 ||| JJ
type  ||| S:335 E:340 ||| NN
I ||| S:340 E:341 ||| PRP
,  ||| S:341 E:343 ||| ,
and  ||| S:343 E:347 ||| CC
CAG  ||| S:347 E:351 ||| NNP
repeats  ||| S:351 E:359 ||| VBZ
associated  ||| S:359 E:370 ||| VBN
with  ||| S:370 E:375 ||| IN
poly-glutamine  ||| S:375 E:390 ||| JJ
diseases ||| S:390 E:398 ||| NNS
.  ||| S:398 E:400 ||| .
We  ||| S:400 E:403 ||| PRP
also  ||| S:403 E:408 ||| RB
report  ||| S:408 E:415 ||| VB
the  ||| S:415 E:419 ||| DT
first  ||| S:419 E:425 ||| JJ
PNA-PNA  ||| S:425 E:433 ||| JJ
duplex  ||| S:433 E:440 ||| NN
containing  ||| S:440 E:451 ||| VBG
mismatches ||| S:451 E:461 ||| NNS
.  ||| S:461 E:463 ||| .
A  ||| S:463 E:465 ||| DT
comparison  ||| S:465 E:476 ||| NN
of  ||| S:476 E:479 ||| IN
the  ||| S:479 E:483 ||| DT
PNA  ||| S:483 E:487 ||| NNP
homoduplex  ||| S:487 E:498 ||| NN
and  ||| S:498 E:502 ||| CC
the  ||| S:502 E:506 ||| DT
PNA-RNA  ||| S:506 E:514 ||| JJ
heteroduplexes  ||| S:514 E:529 ||| NN
reveals  ||| S:529 E:537 ||| VBZ
PNA ||| S:537 E:540 ||| NNP
's  ||| S:540 E:543 ||| POS
intrinsic  ||| S:543 E:553 ||| JJ
structural  ||| S:553 E:564 ||| JJ
properties ||| S:564 E:574 ||| NNS
,  ||| S:574 E:576 ||| ,
shedding  ||| S:576 E:585 ||| VBG
light  ||| S:585 E:591 ||| NN
on  ||| S:591 E:594 ||| IN
its  ||| S:594 E:598 ||| PRP$
reported  ||| S:598 E:607 ||| JJ
sequence  ||| S:607 E:616 ||| NN
selectivity  ||| S:616 E:628 ||| NNS
or  ||| S:628 E:631 ||| CC
intolerance  ||| S:631 E:643 ||| NN
of  ||| S:643 E:646 ||| IN
mismatches  ||| S:646 E:657 ||| NN
when  ||| S:657 E:662 ||| WRB
it  ||| S:662 E:665 ||| PRP
interacts  ||| S:665 E:675 ||| VBD
with  ||| S:675 E:680 ||| IN
nucleic  ||| S:680 E:688 ||| JJ
acids ||| S:688 E:693 ||| NNS
.  ||| S:693 E:695 ||| .
PNA  ||| S:695 E:699 ||| NNP
has  ||| S:699 E:703 ||| VBZ
a  ||| S:703 E:705 ||| DT
much  ||| S:705 E:710 ||| RB
lower  ||| S:710 E:716 ||| RBR
helical  ||| S:716 E:724 ||| JJ
twist  ||| S:724 E:730 ||| NN
than  ||| S:730 E:735 ||| IN
RNA  ||| S:735 E:739 ||| NNP
and  ||| S:739 E:743 ||| CC
the  ||| S:743 E:747 ||| DT
resulting  ||| S:747 E:757 ||| JJ
duplex  ||| S:757 E:764 ||| NN
has  ||| S:764 E:768 ||| VBZ
an  ||| S:768 E:771 ||| DT
intermediate  ||| S:771 E:784 ||| JJ
conformation ||| S:784 E:796 ||| NN
.  ||| S:796 E:798 ||| .
PNA  ||| S:798 E:802 ||| NNP
retains  ||| S:802 E:810 ||| VBZ
its  ||| S:810 E:814 ||| PRP$
overall  ||| S:814 E:822 ||| JJ
conformation  ||| S:822 E:835 ||| NN
while  ||| S:835 E:841 ||| IN
locally  ||| S:841 E:849 ||| RB
there  ||| S:849 E:855 ||| EX
is  ||| S:855 E:858 ||| VBZ
much  ||| S:858 E:863 ||| JJ
disorder ||| S:863 E:871 ||| NN
,  ||| S:871 E:873 ||| ,
especially  ||| S:873 E:884 ||| RB
peptide  ||| S:884 E:892 ||| JJ
bond  ||| S:892 E:897 ||| NN
flipping ||| S:897 E:905 ||| NN
.  ||| S:905 E:907 ||| .
In  ||| S:907 E:910 ||| IN
addition  ||| S:910 E:919 ||| NN
to  ||| S:919 E:922 ||| TO
the  ||| S:922 E:926 ||| DT
Watson-Crick  ||| S:926 E:939 ||| JJ
pairing ||| S:939 E:946 ||| NN
,  ||| S:946 E:948 ||| ,
the  ||| S:948 E:952 ||| DT
structures  ||| S:952 E:963 ||| NNS
contain  ||| S:963 E:971 ||| VBP
interesting  ||| S:971 E:983 ||| JJ
interactions  ||| S:983 E:996 ||| NNS
between  ||| S:996 E:1004 ||| IN
the  ||| S:1004 E:1008 ||| DT
RNA ||| S:1008 E:1011 ||| NNP
's  ||| S:1011 E:1014 ||| POS
phosphate  ||| S:1014 E:1024 ||| JJ
groups  ||| S:1024 E:1031 ||| NNS
and  ||| S:1031 E:1035 ||| CC
the  ||| S:1035 E:1039 ||| DT
Î   ||| S:1039 E:1041 ||| NNP
electrons  ||| S:1041 E:1051 ||| NN
of  ||| S:1051 E:1054 ||| IN
the  ||| S:1054 E:1058 ||| DT
peptide  ||| S:1058 E:1066 ||| JJ
bonds  ||| S:1066 E:1072 ||| NNS
in  ||| S:1072 E:1075 ||| IN
PNA ||| S:1075 E:1078 ||| NNP
.  ||| S:1078 E:1080 ||| .
